User:Oceanflynn/sandbox/William C. Steere Jr.

William Campbell Steere Jr. (Bill Steere) was CEO of Pfizer from 1991 until his retirement in 2001. He focused Pfizer's business on its research-based, global pharmaceutical business.

Career
Steere began working at Pfizer as a medical service representative in 1959 immediately after graduation from Stanford University where his father William Campbell Steere Jr. had been professor from 1950 to 1954 and dean of graduate studies until 1958.

Steere was VP from 1982 to 1984, then EVP from 1984 to 1986. He served as President of Pfizer Pharmaceuticals from 1986 to 1990, President of Pfizer from 1990 to 1991 and CEO from February 1991 to December 2000. He remained on as an influential director on the Board of Directors until 2011. "Steere served as the President and Chief Executive Officer at Pfizer until 1992. He served as the President of Pfizer Pharmaceutical Group. He has in-depth knowledge of the health care industry. He has been the Chairman Emeritus of Pfizer Inc. since July 2001. He served as Chairman of the Board of Pfizer Inc. from 1992 to May 2001. He served as Director of Pfizer Inc. since 1987."

bods
"He served as a Director of Health Management Associates Inc. since May 20, 2003. He served as a Director of MetLife Inc., from August, 1999 to April 27, 2010 and served as its Lead Director from January 18, 2006 to February 1, 2010. He served as a Director of Minerals Technologies Inc., from 1992 to December 31, 2003 and Metropolitan Life Insurance Company since 1997. He served as an Independent Director of Dow Jones & Company Inc. from 1997 to April 18, 2007....[He] "served as the Chairman of Pharmaceutical Manufacturers Association. He has been a Director of Texaco Inc since 1992. He has been an Independent Director of Zoetis Inc. since January 2013. Mr. Steere serves as a Director of WNET-Thirteen, The Business Roundtable, and the New York University Medical Center. He serves as a Director/ Trustee of the New York Botanical Garden and Director of Overseers of Memorial Sloan-Kettering Cancer Center. Mr. Steere serves as a Member of Advisory Board at Private Client Resources, LLC." This person is connected to 24 board members in 2 different organizations across 9 different industries.

Member of the Board of Health Management Associates (2003-) Member of the Board of Metropolitan Life (1999-) Member of the Board of Pfizer (1987-, as Chairman, 1992-2001, continuing) Member of the Board of Dow Jones (1997-2007) Member of the Board of Texaco

education
Steere earned a B.S. in Biology in 1959 from Stanford University where his father William Campbell Steere Jr. had been professor from 1950 to 1954 and dean of the graduate division of Stanford University from 1950 to 1958.

Pharmaceutical Research and Manufacturers of America
Steere was ... in the Pharmaceutical Research and Manufacturers of America, a trade organization which in 2007 included Abbott Laboratories, Amgen, Amylin Pharmaceuticals, Astellas US LLC, AstraZeneca, Bayer HealthCare, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Celgene Corporation, Cephalon, Daiichi Sankyo, EMD Serono, Genzyme, GlaxoSmithKline, Hoffmann-La Roche, Johnson & Johnson, Eli Lilly, MedPointe Pharmaceuticals, Merck, Millennium Pharmaceuticals, Novartis, Organon USA, Otsuka America, Pfizer, Procter & Gamble, Purdue Pharma LP, Sanofi-Aventis, Schering-Plough, Sepracor, Solvay Pharmaceuticals, Valeant Pharmaceuticals and Wyeth.

Early years at Pfizer
"Joined Pfizer directly from Stanford University in 1959, beginning as a sales representative. He held a variety of United States and international sales, marketing, and general management positions and became president of Pfizer Pharmaceuticals in 1986. The board of directors elected him chief executive officer in 1991 and chairman in 1992. During the 1990s, Pfizer emerged as the industry's "partner of choice," marketing not only its own innovation but those of other health care companies as well."

Pfizer breakthroughs 1990s
"Pfizer breakthroughs during the 1990s included market-leaders Norvasc® (amlodipine besylate), Zithromax® (azithromycin), Zoloft® (sertraline hydrochloride), and Viagra®(sildenafil citrate]]). With partners, Pfizer launched Aricept® (donepezil hydrochloride tablets), Celebrex® (celecoxib), and Lipitor® (atorvastatin calcium)."

Mergers and acquisitions
"In late 1999, Steere announced Pfizer's intention to merge with Warner–Lambert, which, like Pfizer, was a fast-growing, global, health care company whose roots extended back to the mid-1800s. In June 2000, Pfizer and Warner-Lambert began operating as a single company with more than 85,000 colleagues worldwide."

Strategies
In the mid-1990s there was a push in the United States towards managed health care. Many drug companies cut their sales force. As the then new CEO of Pfizer, Steere poured money into sales and advertising and hired more sales representatives.

Philanthropy
"In 2002 Mr. Steere and his wife Lynda helped endow the new William and Lynda Steere Herbarium of The New York Botanical Garden, the foundation of the Garden's botanical research program."